Literature DB >> 26393667

More Accurate Modeling of Visual Field Progression in Glaucoma: ANSWERS.

Haogang Zhu1, David P Crabb2, Tuan Ho3, David F Garway-Heath3.   

Abstract

PURPOSE: To validate a method for visual field (VF) progression analysis, called ANSWERS (Analysis with Non-Stationary Weibull Error Regression and Spatial Enhancement), which takes into account increasing measurement variability as glaucoma progresses and spatial correlation among test locations.
METHODS: ANSWERS outputs both a global index of progression and a pointwise estimate of rate of change at each VF location. ANSWERS was compared with linear regression of mean deviation (MD) and permutation of pointwise linear regression (PoPLR). Visual field series of up to 2 years from the United Kingdom Glaucoma Treatment Study were used. This consists of 9104 Swedish Interactive Thresholding Algorithm Standard 24-2 VFs. ANSWERS and PoPLR rate of change were used to predict the VF at the next visit using subseries that were within 7, 13, 18, or 22 months from the baseline. The comparison was carried out on the statistical sensitivity, specificity, and accuracy of predicting future VF.
RESULTS: Across all subseries, statistical sensitivity of ANSWERS in detecting VF deterioration was significantly better than the linear regression of MD and PoPLR, especially in short time series. Prediction accuracy of ANSWERS was better than PoPLR at all series lengths, and the improvement was particularly marked in shorter series. Seventy-five percent of VF series were better predicted by ANSWERS compared with PoPLR. The average prediction error of ANSWERS was 15% lower than that of PoPLR.
CONCLUSIONS: ANSWERS is more sensitive to detect VF progression and predicts future VF loss better than linear regression of MD and PoPLR, especially over short observation periods. (http://www.isrctn.com number, ISRCTN96423140.).

Entities:  

Mesh:

Year:  2015        PMID: 26393667     DOI: 10.1167/iovs.15-16957

Source DB:  PubMed          Journal:  Invest Ophthalmol Vis Sci        ISSN: 0146-0404            Impact factor:   4.799


  21 in total

1.  Evaluation of Visual Field and Imaging Outcomes for Glaucoma Clinical Trials (An American Ophthalomological Society Thesis).

Authors:  David F Garway-Heath; Ana Quartilho; Philip Prah; David P Crabb; Qian Cheng; Haogang Zhu
Journal:  Trans Am Ophthalmol Soc       Date:  2017-08-22

2.  What rates of glaucoma progression are clinically significant?

Authors:  Luke J Saunders; Felipe A Medeiros; Robert N Weinreb; Linda M Zangwill
Journal:  Expert Rev Ophthalmol       Date:  2016-05-13

3.  Improving the Feasibility of Glaucoma Clinical Trials Using Trend-Based Visual Field Progression Endpoints.

Authors:  Zhichao Wu; David P Crabb; Balwantray C Chauhan; Jonathan G Crowston; Felipe A Medeiros
Journal:  Ophthalmol Glaucoma       Date:  2019-01-17

Review 4.  Functional assessment of glaucoma: Uncovering progression.

Authors:  Rongrong Hu; Lyne Racette; Kelly S Chen; Chris A Johnson
Journal:  Surv Ophthalmol       Date:  2020-04-26       Impact factor: 6.048

5.  Comparing 10-2 and 24-2 Visual Fields for Detecting Progressive Central Visual Loss in Glaucoma Eyes with Early Central Abnormalities.

Authors:  Zhichao Wu; Felipe A Medeiros; Robert N Weinreb; Christopher A Girkin; Linda M Zangwill
Journal:  Ophthalmol Glaucoma       Date:  2019-01-14

6.  A view on glaucoma--are we seeing it clearly?

Authors:  D P Crabb
Journal:  Eye (Lond)       Date:  2015-11-27       Impact factor: 3.775

Review 7.  Neuroprotection for glaucoma: Requirements for clinical translation.

Authors:  Leonard A Levin; Megan E Crowe; Harry A Quigley
Journal:  Exp Eye Res       Date:  2016-12-09       Impact factor: 3.467

8.  Pointwise Methods to Measure Long-term Visual Field Progression in Glaucoma.

Authors:  Diana Salazar; Esteban Morales; Alessandro Rabiolo; Vicente Capistrano; Mark Lin; Abdelmonem A Afifi; Fei Yu; Kouros Nouri-Mahdavi; Joseph Caprioli
Journal:  JAMA Ophthalmol       Date:  2020-05-01       Impact factor: 7.389

9.  Development of a Visual Field Simulation Model of Longitudinal Point-Wise Sensitivity Changes From a Clinical Glaucoma Cohort.

Authors:  Zhichao Wu; Felipe A Medeiros
Journal:  Transl Vis Sci Technol       Date:  2018-06-22       Impact factor: 3.283

10.  A novel method to predict visual field progression more accurately, using intraocular pressure measurements in glaucoma patients.

Authors: 
Journal:  Sci Rep       Date:  2016-08-26       Impact factor: 4.379

View more

北京卡尤迪生物科技股份有限公司 © 2022-2023.